Amdocs (NASDAQ:DOX) Updates FY 2026 Earnings Guidance

Amdocs (NASDAQ:DOXGet Free Report) updated its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 7.374-7.444 for the period, compared to the consensus EPS estimate of 7.240. The company issued revenue guidance of $4.7 billion-$4.7 billion, compared to the consensus revenue estimate of $4.7 billion. Amdocs also updated its Q4 2026 guidance to 1.940-2.000 EPS.

Amdocs Stock Performance

Shares of DOX opened at $58.31 on Friday. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.23. Amdocs has a 52-week low of $49.74 and a 52-week high of $90.29. The stock has a 50 day moving average price of $54.49 and a 200 day moving average price of $63.33. The company has a market capitalization of $6.29 billion, a price-to-earnings ratio of 13.90, a price-to-earnings-growth ratio of 0.96 and a beta of 0.40.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The technology company reported $1.84 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.84. Amdocs had a net margin of 9.75% and a return on equity of 20.10%. The firm had revenue of $1.17 billion during the quarter, compared to analysts’ expectations of $1.18 billion. During the same period in the previous year, the company earned $1.72 earnings per share. Amdocs’s quarterly revenue was up 2.7% compared to the same quarter last year. Amdocs has set its Q4 2026 guidance at 1.940-2.000 EPS and its FY 2026 guidance at 7.374-7.444 EPS. Research analysts predict that Amdocs will post 6.56 EPS for the current fiscal year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.569 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.9%. Amdocs’s dividend payout ratio (DPR) is currently 54.05%.

Analyst Ratings Changes

DOX has been the topic of several analyst reports. Cfra downgraded Amdocs to a “sell” rating in a research note on Thursday, May 14th. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a research note on Wednesday. KeyCorp initiated coverage on shares of Amdocs in a report on Monday, June 29th. They issued a “sector weight” rating on the stock. Stifel Nicolaus decreased their price objective on Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Finally, Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a report on Sunday, July 5th. Three research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Amdocs has a consensus rating of “Hold” and an average target price of $86.67.

Check Out Our Latest Analysis on Amdocs

Hedge Funds Weigh In On Amdocs

Hedge funds and other institutional investors have recently modified their holdings of the company. Marex Group plc bought a new position in Amdocs during the 4th quarter worth approximately $214,000. Caitong International Asset Management Co. Ltd boosted its stake in Amdocs by 68.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 795 shares of the technology company’s stock valued at $65,000 after acquiring an additional 323 shares during the period. Sherbrooke Park Advisers LLC bought a new position in shares of Amdocs during the third quarter valued at approximately $255,000. Lido Advisors LLC lifted its holdings in shares of Amdocs by 21.5% in the 3rd quarter. Lido Advisors LLC now owns 2,873 shares of the technology company’s stock worth $237,000 after purchasing an additional 509 shares during the last quarter. Finally, Quadrant Capital Group LLC acquired a new stake in Amdocs in the third quarter worth $72,000. 92.02% of the stock is owned by institutional investors and hedge funds.

About Amdocs

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Read More

Earnings History and Estimates for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.